Sinopharm Covid-19 booster weaker against Omicron - study
Published: Dec 20, 2021 9:52 AM
A Covid-19 booster shot produced by China's Sinopharm had "significantly lower" neutralising activity against the Omicron variant, Chinese researchers said in a paper, although they added the vaccine's efficacy against Omicron remained unclear.
The study - conducted by researchers from Shanghai Jiao Tong University and a Shanghai-based lab specialising in respiratory infectious diseases - compared the activity of Sinopharm's booster vaccine against an older coronavirus strain from Wuhan.
The neutralising antibody activity...
View Comments0
Report this comment
500 characters remaining






Are you sure you want to delete this comment?
This action cannot be undone.